 Michael Yeager
Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 22 | 2021 | 1784 | 2.510 |
Why?
| | Down Syndrome | 5 | 2023 | 328 | 1.750 |
Why?
| | Pulmonary Artery | 7 | 2021 | 1055 | 0.880 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 2 | 2021 | 15 | 0.820 |
Why?
| | Matrix Metalloproteinases | 2 | 2021 | 90 | 0.810 |
Why?
| | Ventricular Function | 1 | 2021 | 60 | 0.780 |
Why?
| | Respiratory Tract Infections | 1 | 2023 | 329 | 0.700 |
Why?
| | Fibroblasts | 6 | 2013 | 835 | 0.630 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2017 | 57 | 0.560 |
Why?
| | Vascular Stiffness | 1 | 2021 | 425 | 0.560 |
Why?
| | Blood Vessels | 2 | 2013 | 187 | 0.510 |
Why?
| | Biomarkers | 2 | 2015 | 3567 | 0.500 |
Why?
| | Lymphoid Tissue | 1 | 2013 | 62 | 0.460 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2012 | 455 | 0.430 |
Why?
| | Lung | 6 | 2023 | 3623 | 0.420 |
Why?
| | Arteritis | 1 | 2012 | 27 | 0.410 |
Why?
| | Unfolded Protein Response | 1 | 2012 | 46 | 0.410 |
Why?
| | Proteomics | 2 | 2015 | 850 | 0.410 |
Why?
| | Proteome | 1 | 2015 | 349 | 0.400 |
Why?
| | Precision Medicine | 1 | 2015 | 354 | 0.390 |
Why?
| | Microsatellite Repeats | 2 | 2002 | 143 | 0.390 |
Why?
| | Mesoderm | 2 | 2011 | 142 | 0.390 |
Why?
| | Phagocytes | 1 | 2011 | 90 | 0.380 |
Why?
| | Myeloid Cells | 1 | 2011 | 127 | 0.370 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 2 | 2002 | 225 | 0.370 |
Why?
| | Lung Diseases | 1 | 2017 | 709 | 0.370 |
Why?
| | Blood Proteins | 1 | 2012 | 240 | 0.370 |
Why?
| | Endothelin-1 | 1 | 2012 | 167 | 0.370 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2012 | 236 | 0.360 |
Why?
| | Immunoglobulin G | 1 | 2013 | 785 | 0.350 |
Why?
| | Endothelium, Vascular | 3 | 2002 | 890 | 0.290 |
Why?
| | Autoantibodies | 1 | 2013 | 1334 | 0.280 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 1795 | 0.260 |
Why?
| | Receptors, Transforming Growth Factor beta | 2 | 2002 | 53 | 0.240 |
Why?
| | Cytokines | 4 | 2017 | 1880 | 0.240 |
Why?
| | Biology | 1 | 2023 | 80 | 0.220 |
Why?
| | Flow Cytometry | 4 | 2019 | 1072 | 0.210 |
Why?
| | Disease Models, Animal | 4 | 2023 | 3676 | 0.210 |
Why?
| | Histone Deacetylase Inhibitors | 2 | 2013 | 200 | 0.200 |
Why?
| | Arterial Pressure | 1 | 2021 | 99 | 0.190 |
Why?
| | DNA-Binding Proteins | 2 | 2012 | 1343 | 0.190 |
Why?
| | Proto-Oncogene Proteins | 2 | 2002 | 618 | 0.190 |
Why?
| | Male | 14 | 2023 | 57474 | 0.180 |
Why?
| | Child | 6 | 2021 | 19033 | 0.180 |
Why?
| | Humans | 23 | 2023 | 118251 | 0.180 |
Why?
| | Prognosis | 2 | 2017 | 3424 | 0.170 |
Why?
| | Rats | 5 | 2013 | 5339 | 0.160 |
Why?
| | Interferon-alpha | 1 | 2019 | 191 | 0.160 |
Why?
| | MicroRNAs | 2 | 2015 | 633 | 0.160 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 65 | 0.150 |
Why?
| | Animals | 13 | 2023 | 33152 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2017 | 3156 | 0.150 |
Why?
| | TRPM Cation Channels | 1 | 2017 | 68 | 0.150 |
Why?
| | Female | 11 | 2023 | 61261 | 0.140 |
Why?
| | Hemodynamics | 1 | 2021 | 1002 | 0.140 |
Why?
| | Blood Flow Velocity | 1 | 2017 | 327 | 0.140 |
Why?
| | Adolescent | 4 | 2021 | 18364 | 0.140 |
Why?
| | Histone Deacetylases | 3 | 2013 | 197 | 0.140 |
Why?
| | Magnetic Resonance Angiography | 1 | 2017 | 210 | 0.140 |
Why?
| | Mutation | 4 | 2003 | 3435 | 0.140 |
Why?
| | Rats, Wistar | 2 | 2013 | 396 | 0.140 |
Why?
| | Gene Expression Profiling | 3 | 2013 | 1590 | 0.130 |
Why?
| | Ventricular Function, Right | 1 | 2017 | 257 | 0.130 |
Why?
| | Inflammation | 4 | 2017 | 2545 | 0.130 |
Why?
| | Cardiovascular System | 1 | 2017 | 127 | 0.130 |
Why?
| | Atrial Natriuretic Factor | 1 | 2015 | 59 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2013 | 2262 | 0.130 |
Why?
| | Breath Tests | 1 | 2015 | 89 | 0.130 |
Why?
| | Cause of Death | 1 | 2017 | 379 | 0.130 |
Why?
| | Chemokine CCL2 | 2 | 2013 | 124 | 0.130 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2015 | 105 | 0.130 |
Why?
| | Heart Ventricles | 2 | 2017 | 725 | 0.130 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 59 | 0.120 |
Why?
| | Phenotype | 4 | 2017 | 2937 | 0.120 |
Why?
| | Fluorescent Antibody Technique | 2 | 2011 | 409 | 0.120 |
Why?
| | Vascular Remodeling | 1 | 2015 | 150 | 0.120 |
Why?
| | Angiotensin II | 1 | 2013 | 107 | 0.110 |
Why?
| | Hypoxia | 4 | 2013 | 957 | 0.110 |
Why?
| | Receptors, Growth Factor | 2 | 2003 | 49 | 0.110 |
Why?
| | Mice | 6 | 2023 | 15446 | 0.110 |
Why?
| | Adventitia | 1 | 2012 | 38 | 0.110 |
Why?
| | Echocardiography | 1 | 2015 | 556 | 0.110 |
Why?
| | Metalloporphyrins | 1 | 2013 | 103 | 0.110 |
Why?
| | Cardiac Catheterization | 2 | 2017 | 541 | 0.110 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2012 | 11 | 0.110 |
Why?
| | Polymerase Chain Reaction | 2 | 2013 | 1004 | 0.110 |
Why?
| | Bronchi | 1 | 2013 | 241 | 0.110 |
Why?
| | Activating Transcription Factor 6 | 1 | 2012 | 17 | 0.110 |
Why?
| | Endothelin A Receptor Antagonists | 1 | 2012 | 24 | 0.110 |
Why?
| | Monocytes | 2 | 2012 | 511 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 817 | 0.100 |
Why?
| | Cell Movement | 2 | 2013 | 888 | 0.100 |
Why?
| | Receptor, Endothelin B | 1 | 2012 | 53 | 0.100 |
Why?
| | Receptor, Endothelin A | 1 | 2012 | 60 | 0.100 |
Why?
| | bcl-2-Associated X Protein | 2 | 2002 | 46 | 0.100 |
Why?
| | Inflammasomes | 1 | 2013 | 120 | 0.100 |
Why?
| | Fibrosis | 1 | 2013 | 480 | 0.100 |
Why?
| | Leukocyte Common Antigens | 1 | 2011 | 76 | 0.100 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 154 | 0.100 |
Why?
| | Chemokine CXCL12 | 1 | 2011 | 79 | 0.100 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 173 | 0.100 |
Why?
| | Cell Count | 1 | 2011 | 315 | 0.100 |
Why?
| | Peptide Fragments | 1 | 2015 | 700 | 0.100 |
Why?
| | Immunomodulation | 1 | 2011 | 89 | 0.100 |
Why?
| | Transforming Growth Factor beta | 2 | 2004 | 461 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2013 | 497 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2013 | 442 | 0.090 |
Why?
| | Stem Cells | 2 | 2012 | 556 | 0.090 |
Why?
| | Cell Separation | 1 | 2011 | 293 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 700 | 0.090 |
Why?
| | Vasodilator Agents | 1 | 2012 | 328 | 0.090 |
Why?
| | Hyaluronic Acid | 1 | 2012 | 196 | 0.090 |
Why?
| | Ventricular Remodeling | 1 | 2012 | 228 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2015 | 717 | 0.090 |
Why?
| | Arrhythmias, Cardiac | 1 | 2011 | 277 | 0.090 |
Why?
| | Carrier Proteins | 1 | 2013 | 725 | 0.080 |
Why?
| | Infant | 2 | 2012 | 8254 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2262 | 0.080 |
Why?
| | Child, Preschool | 2 | 2012 | 9448 | 0.080 |
Why?
| | Autoimmunity | 1 | 2013 | 831 | 0.080 |
Why?
| | Signal Transduction | 3 | 2013 | 4688 | 0.080 |
Why?
| | Phosphorylation | 1 | 2012 | 1622 | 0.080 |
Why?
| | Epigenesis, Genetic | 1 | 2011 | 536 | 0.070 |
Why?
| | Young Adult | 2 | 2011 | 10731 | 0.070 |
Why?
| | Pneumonia | 1 | 2011 | 579 | 0.070 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2005 | 11 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2015 | 2433 | 0.070 |
Why?
| | Angiopoietins | 1 | 2003 | 14 | 0.060 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 33 | 0.060 |
Why?
| | Transcription Factors | 1 | 2012 | 1567 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3169 | 0.060 |
Why?
| | Risk Factors | 1 | 2017 | 8958 | 0.060 |
Why?
| | Herpesvirus 8, Human | 1 | 2003 | 68 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2002 | 764 | 0.050 |
Why?
| | Base Pair Mismatch | 1 | 2002 | 15 | 0.050 |
Why?
| | MutS Homolog 2 Protein | 1 | 2002 | 14 | 0.050 |
Why?
| | Frameshift Mutation | 1 | 2002 | 28 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2002 | 54 | 0.050 |
Why?
| | Herpesviridae Infections | 1 | 2003 | 140 | 0.050 |
Why?
| | Lymphokines | 1 | 2002 | 121 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 817 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2017 | 4887 | 0.050 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2002 | 229 | 0.050 |
Why?
| | DNA Mutational Analysis | 1 | 2001 | 379 | 0.040 |
Why?
| | Cattle | 2 | 2013 | 974 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2001 | 871 | 0.040 |
Why?
| | Cell Division | 1 | 2001 | 775 | 0.040 |
Why?
| | Adult | 4 | 2019 | 31324 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2012 | 9319 | 0.040 |
Why?
| | Listeriosis | 1 | 2017 | 60 | 0.040 |
Why?
| | Base Sequence | 1 | 2001 | 2148 | 0.040 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2017 | 154 | 0.040 |
Why?
| | Listeria monocytogenes | 1 | 2017 | 110 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 980 | 0.030 |
Why?
| | Blotting, Western | 2 | 2011 | 1186 | 0.030 |
Why?
| | Cell Line | 1 | 2001 | 2693 | 0.030 |
Why?
| | Macrophages | 2 | 2012 | 1311 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 571 | 0.030 |
Why?
| | Stroke Volume | 1 | 2017 | 513 | 0.030 |
Why?
| | Apoptosis | 2 | 2002 | 2461 | 0.030 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2013 | 14 | 0.030 |
Why?
| | DNA | 1 | 2001 | 1385 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 68 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 709 | 0.030 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 64 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 108 | 0.030 |
Why?
| | Immunoblotting | 1 | 2013 | 304 | 0.030 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 141 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 191 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 181 | 0.030 |
Why?
| | Vasa Vasorum | 1 | 2012 | 32 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2013 | 345 | 0.030 |
Why?
| | Caspase 1 | 1 | 2013 | 143 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2013 | 149 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2017 | 744 | 0.030 |
Why?
| | Connective Tissue | 1 | 2011 | 37 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2013 | 225 | 0.030 |
Why?
| | Benzamides | 1 | 2012 | 176 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 2664 | 0.020 |
Why?
| | Cell Cycle | 1 | 2013 | 547 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 338 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2013 | 377 | 0.020 |
Why?
| | Macrophage Activation | 1 | 2011 | 165 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 27510 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2012 | 417 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2011 | 435 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2012 | 414 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2011 | 804 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 382 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4574 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 436 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 1969 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1482 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1322 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2434 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1746 | 0.020 |
Why?
| | Prospective Studies | 1 | 2017 | 6443 | 0.020 |
Why?
| | Densitometry | 1 | 2005 | 30 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 25 | 0.020 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2005 | 56 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2005 | 195 | 0.020 |
Why?
| | Blood Pressure | 1 | 2012 | 1656 | 0.020 |
Why?
| | Epithelium | 1 | 2005 | 303 | 0.020 |
Why?
| | Bone Morphogenetic Protein Receptors | 1 | 2003 | 4 | 0.020 |
Why?
| | Species Specificity | 1 | 2005 | 559 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4044 | 0.010 |
Why?
| | Genes, Viral | 1 | 2003 | 93 | 0.010 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2003 | 48 | 0.010 |
Why?
| | Cyclins | 1 | 2003 | 79 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2005 | 822 | 0.010 |
Why?
| | Down-Regulation | 1 | 2005 | 623 | 0.010 |
Why?
| | Arteries | 1 | 2004 | 250 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2002 | 66 | 0.010 |
Why?
| | Hypertrophy | 1 | 2002 | 121 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 862 | 0.010 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 102 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2005 | 444 | 0.010 |
Why?
| | DNA, Viral | 1 | 2003 | 351 | 0.010 |
Why?
| | Viral Proteins | 1 | 2003 | 290 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2003 | 748 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2002 | 523 | 0.010 |
Why?
| | RNA | 1 | 2001 | 830 | 0.010 |
Why?
|
|
Yeager's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|